XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.1
1. Basis of Presentation and Use of Estimates Organization, Consolidation and Presentation of Financial Statements (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 726,796 $ 571,644    
Cost of goods sold 326,169 254,276    
Deferred Revenue 66,200   $ 60,000  
Retained earnings 10,245,426   9,268,012  
Accumulated other comprehensive loss 68,434   282,456  
Total stockholders' equity $ 10,609,059 $ 6,293,079 9,879,940 $ 5,755,057
Revenue Allocation Percent To Lease Elements 2.00% 3.00%    
Additional paid-in-capital $ 445,101   429,376  
Selling, general and administrative expense 225,853 $ 193,692    
Research and Development Expense 73,912 49,303    
Interest expense 398 5,690    
Other Nonoperating Income (Expense) 17,407 3,273    
Deferred Revenue, Current 48,000   $ 42,500  
Europe [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 247,700 195,700    
Asia Pacific [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 168,900 111,400    
UNITED STATES        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 271,400 229,500    
Americas [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 38,800 $ 35,000